[1]
|
Zhang, J., Wu, X., Gao, P. and Yan, P. (2017) Correlations of Serum Cystatin C and Glomerular Filtration Rate with Vascular Lesions and Severity in Acute Coronary Syndrome. BMC Cardiovascular Disorders, 17, Article No. 47.
https://doi.org/10.1186/s12872-017-0483-8
|
[2]
|
Virani, S.S., Alonso, A., Benjamin, E.J., Bittencourt, M.S., Callaway, C.W., Carson, A.P., et al. (2020) Heart Disease and Stroke Statistics-2020 Update: A Report from the American Heart Association. Circulation, 141, e139-e596.
https://doi.org/10.1161/CIR.0000000000000757
|
[3]
|
Tan, Z., Li, L., Ma, Y. and Geng, X.B. (2019) Clinical Significance of Cys-C and hs-CRP in Coronary Heart Disease Patients Undergoing Percutaneous Coronary Intervention. Brazilian Journal of Cardiovascular Surgery, 34, 17-21.
https://doi.org/10.21470/1678-9741-2018-0171
|
[4]
|
Shlipak, M.G., Sarnak, M.J., Katz, R., Fried, L.F., Seliger, S.L., Newman, A.B., et al. (2005) Cystatin C and the Risk of Death and Cardiovascular Events among Elderly Persons. The New England Journal of Medicine, 352, 2049-2060.
https://doi.org/10.1056/NEJMoa043161
|
[5]
|
Shlipak, M.G., Sarnak, M.J., Katz, R., Fried, L.F., Seliger, S., Newman, A., et al. (2005) Cystatin-C and Mortality in Elderly Persons with Heart Failure. Journal of the American College of Cardiology, 45, 268-271.
https://doi.org/10.1016/j.jacc.2004.09.061
|
[6]
|
Coll, E., Botey, A., Alvarez, L., Poch, E., Quintó, L., Saurina, A., et al. (2000) Serum Cystatin C as a New Marker for Noninvasive Estimation of Glomerular Filtration Rate and as a Marker for Early Renal Impairment. American Journal of Kidney Diseases, 36, 29-34. https://doi.org/10.1053/ajkd.2000.8237
|
[7]
|
Abid, L., Charfeddine, S., Kammoun, S., Turki, M. and Ayedi, F. (2016) Cystatin C: A Prognostic Marker after Myocardial Infarction in Patients without Chronic Kidney Disease. Journal of the Saudi Heart Association, 28, 144-151.
https://doi.org/10.1016/j.jsha.2015.10.001
|
[8]
|
Maahs, D.M., Ogden, L.G., Kretowski, A., Snell-Bergeon, J.K., Kinney, G.L., Berl, T., et al. (2007) Serum Cystatin C Predicts Progression of Subclinical Coronary Atherosclerosis in Individuals with Type 1 Diabetes. Diabetes, 56, 2774-2779.
https://doi.org/10.2337/db07-0539
|
[9]
|
Knight, E.L., Verhave, J.C., Spiegelman, D., Hillege, H.L., De Zeeuw, D., Curhan, G.C., et al. (2004) Factors Influencing Serum Cystatin C Levels Other than Renal Function and the Impact on Renal Function Measurement. Kidney International, 65, 1416-1421. https://doi.org/10.1111/j.1523-1755.2004.00517.x
|
[10]
|
Ge, C., Ren, F., Lu, S., Ji, F., Chen, X. and Wu, X. (2009) Clinical Prognostic Significance of Plasma Cystatin C Levels among Patients with Acute Coronary Syndrome. Clinical Cardiology, 32, 644-648.
https://doi.org/10.1002/clc.20672
|
[11]
|
Levine, G.N., Bates, E.R., Bittl, J.A., Brindis, R.G., Fihn, S.D., Fleisher, L.A., et al. (2016) 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients with Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines: An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention, 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery, 2012 ACC/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart Disease, 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction, 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes, and 2014 ACC/AHA Guideline on Perioperative Cardiovascular Evaluation and Management of Patients Undergoing Noncardiac Surgery. Circulation, 134, e123-e155.
https://doi.org/10.1161/CIR.0000000000000404
|
[12]
|
Amsterdam, E.A., Wenger, N.K., Brindis, R.G., Casey Jr., D.E., Ganiats, T.G., Holmes Jr., D.R., et al. (2014) 2014 AHA/ACC Guideline for the Management of Patients with Non-ST-Elevation Acute Coronary Syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation, 140, e344-e426. https://doi.org/10.1161/CIR.0000000000000134
|
[13]
|
O’gara, P.T., Kushner, F.G., Ascheim, D.D., Casey Jr., D.E., Chung, M.K., de Lemos, J.A., et al. (2013) 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction: Executive Summary: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Journal of the American College of Cardiology, 61, 485-510. https://doi.org/10.1016/j.jacc.2012.11.018
|
[14]
|
Rampidis, G.P., Benetos, G., Benz, D.C., Giannopoulos, A.A. and Buechel, R.R. (2019) A Guide for Gensini Score Calculation. Atherosclerosis, 287, 181-183. https://doi.org/10.1016/j.atherosclerosis.2019.05.012
|
[15]
|
中国医师协会急诊医师分会, 国家卫健委能力建设与继续教育中心急诊学专家委员会, 中国医疗保健国际交流促进会急诊急救分会. 急性冠脉综合征急诊快速诊治指南(2019) [J]. 中华急诊医学杂志, 2019, 28(4): 421-428.
|
[16]
|
Van Holten, T.C., Waanders, L.F., De Groot, P.G., Vissers, J., Hoefer, I.E., Pasterkamp, G., et al. (2013) Circulating Biomarkers for Predicting Cardiovascular Disease Risk; A Systematic Review and Comprehensive Overview of Meta-Analyses. PLoS ONE, 8, e62080. https://doi.org/10.1371/journal.pone.0062080
|
[17]
|
Taglieri, N., Koenig, W. and Kaski, J.C. (2009) Cystatin C and Cardiovascular Risk. Clinical Chemistry, 55, 1932-1943.
https://doi.org/10.1373/clinchem.2009.128397
|
[18]
|
Hamzic-Mehmedbasic, A. (2016) Inflammatory Cytokines as Risk Factors for Mortality after Acute Cardiac Events. Medical Archives, 70, 252-255. https://doi.org/10.5455/medarh.2016.70.252-255
|
[19]
|
Hoke, M., Amighi, J., Mlekusch, W., Schlager, O., Exner, M., Sabeti, S., et al. (2010) Cystatin C and the Risk for Cardiovascular Events in Patients with Asymptomatic Carotid Atherosclerosis. Stroke, 41, 674-679.
https://doi.org/10.1161/STROKEAHA.109.573162
|
[20]
|
Huang, Q., Shen, W., Li, J., Luo, X., Shi, H., Yan, P., et al. (2019) Association of Serum Cystatin C Levels with Acute Coronary Syndrome in Patients of Advanced Age. Journal of International Medical Research, 47, 1987-1997.
https://doi.org/10.1177%2F0300060519833576
|
[21]
|
Negrusz-Kawecka, M., Poreba, R., Hulok, A., Sciborski, K., Marczak, J. and Bańkowski, T. (2014) Evaluation of the Significance of Cystatin C Levels in Patients Suffering from Coronary Artery Disease. Advances in Clinical and Experimental Medicine, 23, 551-558.
|
[22]
|
Alhusseiny, A.H., Al-Nimer, M.S. and Al-Neamy, S.I. (2015) Assessment of Serum Cystatin C Levels in Newly Diagnosed Acute Myocardial Infarction at the Onset and at the Time of Hospital Discharge. Cardiology Research, 6, 226-231. http://dx.doi.org/10.14740/cr377w
|
[23]
|
Lodh, M., Parida, A., Sanyal, J. and Ganguly, A. (2013) Cystatin C in Acute Coronary Syndrome. International Federation of Clinical Chemistry and Laboratory Medicine, 24, 61-67.
|